Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 01, 2017 07:00 ET | Source: Curis, Inc.

Curis Announces Upcoming Presentation at the American Society of Hematology 59th Annual Meeting & Exposition

LEXINGTON, Mass., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for...
November 07, 2017 07:00 ET | Source: Curis, Inc.

Curis Reports Third Quarter 2017 Financial Results

LEXINGTON, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates...
November 03, 2017 07:00 ET | Source: Curis, Inc.

Curis to Present at the Society for Immunotherapy of Cancer 32nd Annual Meeting and the Cowen IO NEXT Summit

LEXINGTON, Mass., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for...
November 01, 2017 07:00 ET | Source: Curis, Inc.

Curis to Release Third Quarter 2017 Financial Results and Hold Conference Call on November 7, 2017

LEXINGTON, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the...
September 22, 2017 11:54 ET | Source: Curis, Inc

Curis to Present at the Cantor Fitzgerald Global Healthcare Conference

LEXINGTON, Mass., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for...
September 14, 2017 07:00 ET | Source: Curis, Inc

Curis Announces Pricing of Public Offering of Common Stock

LEXINGTON, Mass., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company, today announced the pricing of an underwritten public offering of 20,000,000 shares of its...
September 13, 2017 16:04 ET | Source: Curis, Inc

Curis Announces Proposed Public Offering of Common Stock

LEXINGTON, Mass., Sept. 13, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company, today announced its intention to offer and sell up to 20 million shares of its common stock...
September 11, 2017 04:00 ET | Source: Curis, Inc

Curis and Aurigene Announce CA-170 Program Update Following Data Presented at ESMO 2017

-- Results from 34 Patients Demonstrate Positive Safety Profile and Support Decision to Expand Development -- -- Aurigene and Curis Plan Clinical Trial of CA-170 in India -- LEXINGTON, Mass., Sept. ...
September 06, 2017 07:00 ET | Source: Curis, Inc

Curis to Present at the Baird 2017 Global Healthcare Conference

LEXINGTON, Mass., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for...
August 31, 2017 07:00 ET | Source: Curis, Inc

Curis Announces CA-170 Poster Presentation at ESMO 2017 Congress

LEXINGTON, Mass., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for...